By comparing viruses in parts of China with or without endemic EBV-associated nasal cancers, researchers narrowed in on two viral variants associated with increased cancer risk.
The novel technology uses DNA-barcoded antibodies to enable single-cell RNA sequencing platforms to detect and quantify protein expression.
While the '3G' study did not establish clinical utility, the researchers said it shows genomic profiling to guide gastric cancer treatment is feasible.
Under the agreement, the researchers plan to sequence 150 AML genomes and transcriptomes to look for population-specific variants.
The Singaporean firm already offers cell-free NIPT testing through its iGene Laboratory and sells a kit to test ovarian cysts for malignancy.
In Nature this week: trove of data from the Genotype Tissue Expression consortium, and more.
Using new genome and transcriptome sequences, researchers saw expansions and expression jumps in sulfur and fruit ripening pathways in Durio zibethinus.
The partners will work with academic and industrial partners in biomedical research with the goal of accelerating cancer detection and screening.
The university will have access to the Agilent technology for use in a study of patient responses to cardiovascular drugs.
NEW YORK (GenomeWeb News) – A new company spun out of the National University of Singapore (NUS) launched today with a technology that it said can instantly provide a diagnosis for gastric and esophageal cancers during endoscopy.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.